| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | RVTY Revvity, Inc. | Singh Prahlad R.53 | Please See Remarks | Sell | 1,144 | $105.13 | $120,268.72 | -1.1% | +7.1% | +9.0% | |
| Feb 22, 2024 | CRL Charles River Laboratories International, Inc. | Barbo William D66 | Corporate Executive VP &CCO | Sell | 4,050 | $248.50 | $1,006,425.00 | -15.0% | -11.3% | -34.0% | |
| Feb 22, 2024 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 291 | $59.78 | $17,395.98 | -3.9% | -10.1% | -17.2% | |
| Feb 22, 2024 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, Screening | Sell | 1,013 | $59.78 | $60,557.14 | -9.5% | -10.1% | -17.2% | |
| Feb 22, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 136,012 | $392.66 | $53,406,441.28 | -1.2% | -1.0% | -13.6% | |
| Feb 22, 2024 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 11,565 | $59.78 | $691,355.70 | -0.9% | -10.1% | -17.2% | |
| Feb 22, 2024 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 136,012 | $392.66 | $53,406,441.28 | -1.2% | -1.0% | -13.6% | |
| Feb 22, 2024 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 1,351 | $59.78 | $80,762.78 | -21.1% | -10.1% | -17.2% | |
| Feb 22, 2024 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 1,013 | $59.78 | $60,557.14 | -1.4% | -10.1% | -17.2% | |
| Feb 22, 2024 | EXAS Exact Sciences Corp | Cunningham Everett54 | Chief Commercial Officer | Sell | 1,350 | $59.78 | $80,703.00 | -3.3% | -10.1% | -17.2% | |
| Feb 22, 2024 | EXAS Exact Sciences Corp | Coward D Scott77 | Director | Sell | 663 | $59.78 | $39,634.14 | -1.5% | -10.1% | -17.2% | |
| Feb 22, 2024 | EXAS Exact Sciences Corp | Baranick Brian75 | Gen. Mgr., Precision Oncology | Sell | 1,093 | $59.78 | $65,339.54 | -10.1% | -10.1% | -17.2% | |
| Feb 21, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,000,000 | $0.99 | $991,700.00 | +0.5% | +28.7% | +65.3% | |
| Feb 21, 2024 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, Screening | Sell | 1,078 | $61.50 | $66,297.00 | -11.1% | -15.4% | -21.8% | |
| Feb 21, 2024 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 4,975 | $61.50 | $305,962.50 | -0.4% | -15.4% | -21.8% | |
| Feb 21, 2024 | EXAS Exact Sciences Corp | Coward D Scott77 | Director | Sell | 706 | $61.50 | $43,419.00 | -1.6% | -15.4% | -21.8% | |
| Feb 21, 2024 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 415 | $61.50 | $25,522.50 | -5.6% | -15.4% | -21.8% | |
| Feb 21, 2024 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 1,493 | $61.50 | $91,819.50 | -28.7% | -15.4% | -21.8% | |
| Feb 21, 2024 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 1,079 | $61.50 | $66,358.50 | -1.5% | -15.4% | -21.8% | |
| Feb 21, 2024 | EXAS Exact Sciences Corp | Baranick Brian75 | Gen. Mgr., Precision Oncology | Sell | 895 | $61.50 | $55,042.50 | -9.2% | -15.4% | -21.8% | |
| Feb 20, 2024 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 63,988 | $390.58 | $24,992,323.32 | -0.6% | +3.4% | -10.5% | |
| Feb 20, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 63,988 | $390.58 | $24,992,323.32 | -0.6% | +3.4% | -10.5% | |
| Feb 16, 2024 | IQV Iqvia Holdings Inc. | Knightly Kevin C57 | See Remarks | Sell | 13,468 | $241.10 | $3,247,165.38 | -31.1% | -1.5% | -18.9% | |
| Feb 16, 2024 | NTRA Natera, Inc. | Rosenman Herm46 | Director | Sell | 93,901 | $69.37 | $6,514,371.49 | -37.1% | +55.0% | +147.7% | |
| Feb 16, 2024 | IQV Iqvia Holdings Inc. | Sherbet Eric57 | See Remarks | Sell | 1,000 | $241.50 | $241,500.00 | -4.6% | -1.5% | -18.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.